Companion Diagnostic Technologies Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Companion Diagnostic Technologies Market was valued at USD 4,865.60 million in 2020, and it is expected to reach USD 14,920.22 million by 2028, registering a CAGR of 20% during the forecast period 2022-2028.

Companion diagnostic tests provide essential information for the safe and efficient use of subsequent drugs or biologics. Companion diagnostics technologies are co-developed for use in drug development to facilitate the selection or exclusion of groups of patients for drug treatment with specific drugs based on the biological characteristics that define responders and non-responders to treatment. Therefore, the increasing use of companion diagnostics technologies in drug development for the treatment of diseases can boost the growth of the global market. Additionally, increasing demand for personalized medicine, increasing discovery of biomarkers as drug targets, and increasing number of cardiovascular and neurological disease cases are some of the factors responsible for the high CAGR of the market during the forecast period.


Market Segments

BY INDICATIONS

  • Oncology 
  • Cardiovascular 
  • Central Nervous System 
  • Auto immune & Inflammation 
  • Virology
  • Others

BY TECHNOLOGY 

  • Immunohistochemistry
  • Molecular diagnostics

Key Players

Companies profiled in this report include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Inc., Ventana Medical Systems, bioMerieux, Myriad Genetics, Inc., Resonance Health Ltd., Leica Microsystems, and Life Technologies.


Scope of the Report

The research study analyzes the global Companion Diagnostic Technologies industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment


Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Companion Diagnostic Technologies Market Report

1. What was the Companion Diagnostic Technologies Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Companion Diagnostic Technologies Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Companion Diagnostic Technologies Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation